BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22798155)

  • 1. US-guided botulinum toxin injection for excessive drooling in children.
    Çiftçi T; Akıncı D; Yurttutan N; Akhan O
    Diagn Interv Radiol; 2013; 19(1):56-60. PubMed ID: 22798155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided injection of botulinum toxin A into the submandibular gland in children and young adults with sialorrhoea.
    Gok G; Cox N; Bajwa J; Christodoulou D; Moody A; Howlett DC
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):231-3. PubMed ID: 22939893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration.
    Pena AH; Cahill AM; Gonzalez L; Baskin KM; Kim H; Towbin RB
    J Vasc Interv Radiol; 2009 Mar; 20(3):368-73. PubMed ID: 19157908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Experience of Treating Drooling with Repeated Botulinum Toxin Injections.
    Sillanpää S; Sipilä M; Numminen J; Rautiainen M
    ORL J Otorhinolaryngol Relat Spec; 2015; 77(6):333-8. PubMed ID: 26418063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
    Reid SM; Walstab JE; Chong D; Westbury C; Reddihough DS
    J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
    Sidebottom AJ; May JE; Madahar AK
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided botulinum toxin injections for treatment of drooling.
    Breheret R; Bizon A; Jeufroy C; Laccourreye L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands.
    Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R
    Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
    Chan KH; Liang C; Wilson P; Higgins D; Allen GC
    JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ; Dahl JP; Rose AS
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
    Sriskandan N; Moody A; Howlett DC
    Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A as a treatment for excessive drooling in children.
    Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
    Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.